Cellular leiomyoma: A 10-year retrospective analysis of clinical features, and recurrence risk

Yang Ming, Ming Y, Ming Yang, Ting Liang, Liang T, Lu Wang, Wang L, Duosheng Jiang, Jiang D, Tongfu Feng
Journal of Obstetrics and Gynaecology Research · 2025 · vol. 51(7) , pp. e16359 · doi:10.1111/jog.16359 · PMID:40628373 · W4412122984
article OA: closed CC0
Full text JSON View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

Cellular leiomyoma, distinct from typical uterine leiomyoma, is associated with adenomyosis and late menarche, and its myomectomy recurrence risk is increased by multiple fibroids but decreased by hysteroscopic submucosal fibroid removal.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

OBJECTIVES: In this study, we aimed to compare the clinical characteristics of cellular leiomyoma (CL) with those of typical uterine leiomyoma (UL) and explore recurrence risk factors in patients with CL myomectomy. STUDY DESIGN: In this retrospective cohort study, we analyzed medical records of patients diagnosed with CL (n = 102) and UL (n = 105) who underwent surgery between January 2013 and May 2023. Postoperative prognosis was assessed through patient follow-up until June 2024. RESULTS: Patients with CL were likelier to have adenomyosis (odds ratio [OR], 4.06; 95% confidence interval [CI], 1.28-12.88; p = 0.017) and late-age menarche (OR, 1.50; 95% CI, 1.15-1.95; p = 0.002). A uterus that has three or fewer fibroids (OR, 2.14; 95% CI, 1.05-4.37; p = 0.037) was more likely to develop into CL than the control group. Concerning the predictive aspect, more than three fibroids are associated with a higher risk of recurrence (OR, 5.33; 95% CI, 1.02-27.76; p = 0.047). The use of hysteroscopy to remove submucosal fibroids is associated with a lower risk (OR, 0.08; 95% CI, 0.01-0.78; p = 0.030). CONCLUSIONS: This study confirms that CL exhibits distinct clinical characteristics from ULs, with a higher postoperative recurrence rate and risks of malignant transformation and abdominal dissemination. Our study identified for the first time that adenomyosis is an independent risk factor for CL. Additionally, submucous fibroids tend to be resected while still small, allowing for more complete removal and reducing recurrence risk. An increased number of fibroids was also identified as a risk factor for recurrence.
Full text 2,133 characters · extracted from oa-doi-fallback · 3 sections · click to expand

Abstract

Objectives In this study, we aimed to compare the clinical characteristics of cellular leiomyoma (CL) with those of typical uterine leiomyoma (UL) and explore recurrence risk factors in patients with CL myomectomy. Study Design In this retrospective cohort study, we analyzed medical records of patients diagnosed with CL (n = 102) and UL (n = 105) who underwent surgery between January 2013 and May 2023. Postoperative prognosis was assessed through patient follow-up until June 2024.

Results

Patients with CL were likelier to have adenomyosis (odds ratio [OR], 4.06; 95% confidence interval [CI], 1.28–12.88; p = 0.017) and late-age menarche (OR, 1.50; 95% CI, 1.15–1.95; p = 0.002). A uterus that has three or fewer fibroids (OR, 2.14; 95% CI, 1.05–4.37; p = 0.037) was more likely to develop into CL than the control group. Concerning the predictive aspect, more than three fibroids are associated with a higher risk of recurrence (OR, 5.33; 95% CI, 1.02–27.76; p = 0.047). The use of hysteroscopy to remove submucosal fibroids is associated with a lower risk (OR, 0.08; 95% CI, 0.01–0.78; p = 0.030).

Conclusions

This study confirms that CL exhibits distinct clinical characteristics from ULs, with a higher postoperative recurrence rate and risks of malignant transformation and abdominal dissemination. Our study identified for the first time that adenomyosis is an independent risk factor for CL. Additionally, submucous fibroids tend to be resected while still small, allowing for more complete removal and reducing recurrence risk. An increased number of fibroids was also identified as a risk factor for recurrence. CONFLICT OF INTEREST STATEMENT The authors declare no conflict of interests for this article. DATA AVAILABILITY STATEMENT Due to ethical restrictions and patient privacy protection regulations, the raw data cannot be publicly shared. Summary data supporting the findings are presented in Tables 1–5 and Appendices 1 and 2 of this article. For further inquiries, please contact the corresponding author.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

adenomyosis

MeSH descriptors

Leiomyoma Leiomyoma Leiomyoma Leiomyoma Leiomyoma Leiomyoma Leiomyoma Leiomyoma Leiomyoma Leiomyoma Leiomyoma Leiomyoma Leiomyoma Leiomyoma Leiomyoma Leiomyoma Leiomyoma Leiomyoma Leiomyoma Leiomyoma

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (3)

References (25)

Source provenance

europepmc
last seen: 2026-08-01T06:07:04.264727+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-08-01T06:03:43.567891+00:00
unpaywall
last seen: 2026-08-01T06:38:12.426807+00:00
License: CC0 · commercial use OK